
GC75785
F44-A13
Also known as [2-[[tert-butylcarbamoyl(cyclopropylmethyl)amino]methyl]-5-(diethylamino)phenyl] 4-acetamidobenzenesulfonate
F44-A13 is an orally active and highly selective farnesoid X receptor (FXR) antagonist with an IC50 value of 1·1 μM
ChemicalCAS1338190-14-9MW544.71FormulaC28H40N4O5S
- CAS number
- 1338190-14-9
- Molecular weight
- 544.71
- Formula
- C28H40N4O5S
- InChIKey
- ARHQGFNNEONRES-UHFFFAOYSA-N
- Catalogue number
- GC75785
- Brand
- GLPBIO
Computed properties PubChem CID 83279418 · XLogP 3.9 · TPSA 116 Ų · H-bond donors 2
- XLogP
- 3.9
- TPSA
- 116 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 12
- Heavy atoms
- 38
SMILES CCN(CC)C1=CC(=C(C=C1)CN(CC2CC2)C(=O)NC(C)(C)C)OS(=O)(=O)C3=CC=C(C=C3)NC(=O)C
Computed descriptors from PubChem (CID 83279418), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il